Australia

PRESCIENT THERAPEUTICS LIMITED (PTX)

Not featured in screeners

Not featured in screeners

Insider activity signals

0 activity signals detected for PRESCIENT THERAPEUTICS LIMITED

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Download results Settings

James Campbell Director

Transaction date 11 Oct 2022

Planned purchase

Price

88.73

Quantity 99,991

Value A$4,002,610

Steven Lee Yatomi-Clarke Director

Transaction date 11 Oct 2022

Planned purchase

Price

57.15

Quantity 12,026

Value A$210,082

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2022-10-12	2022-10-11	PP Planned purchase	James Campbell Director	99,991 88.73 A$4,002,610	99,991	88.73	A$4,002,610
2022-10-12	2022-10-11	PP Planned purchase	Steven Lee Yatomi-Clarke Director	12,026 57.15 A$210,082	12,026	57.15	A$210,082

More insider trading research around PRESCIENT THERAPEUTICS LIMITED